JPRN-UMIN000003847尚未招募4 期
Effect of AT1 receptor blocker plus low-dose diuretics and Ca blocker on home blood pressure - PLES TRIA
Department of General Internal Medicine, Saitama Medical School0 个研究点目标入组 40 人开始时间: 2010年6月30日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Secondary Hypertension CVD within 6 months Ischemic heart disease within 6months Heart failure over NYHA III Severe Liver disease Severe Kidney disease
研究者
相似试验
招募中
不适用
The study of efficacy of AT1 receptor blocker, olmesartan and calcium antagonists , azelnidipine combination therapy in patients with essential hypertension , diabetic or chronic kidney diseasePatient with essential hypertension, diabetic or chronic kidney diseaseJPRN-UMIN000004750Kochi Medical School200
招募中
不适用
The effect of AT1 receptor blocker/Ca antagonist combination drug on hypertensive patients - Effect of change in medication from AT1 receptor blocker/Ca antagonist concurrent dosage to its combination drugHypertensionJPRN-UMIN000007701Chiba University Hospital100
尚未招募
4 期
Effect of ARB and diuretics combination therapy on home blood pressure by using telemedicine systemHypertensionJPRN-UMIN000003846Department of General Internal Medicine, Saitama Medical School50
已完成
不适用
Efficacy of ARB and low dose diuretic combination in type 2 diabetics with hypertensioType 2 diabetes mellitus with hypertensionJPRN-UMIN000011276First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health50
进行中（未招募）
1 期
Importance of ARB medication in preventing valvular heart diseaseEUCTR2018-004653-24-DKOdense Universitets Hospital280